Visit: 60 Corporate Woods, Suite 380 | Email: URVenturesInfo@urmc.rochester.edu | Phone: 585-276-6600
Research that has transformed scientists’ understanding of the brain and neurodegenerative diseases like Alzheimer’s has been awarded the 2014 Newcomb Cleveland Prize of the American Association for the Advancement of Science (AAAS). The Association’s oldest honor, the prize annually recognizes the author or authors of
Amy Or, Wall Street Journal, 17 December 2014 Norwest Venture Partners’ portfolio company iCardiac Technologies Inc. may have a way to help pharmaceutical companies detect which experimental drugs might flat line over cardiac concerns. The Rochester, N.Y.-based company recently completed a study in collaboration with
Chunlei Guo, professor of optics, is scheduled to be a guest on Science Friday today at 2 p.m. Guo is set to talk about his research on using lasers to create superhydrophobic metals. The show airs on NPR. Tune in locally to WXXI AM1370.
The National Science Foundation today announced that the University of Rochester has been selected for an I-Corps site Award. This 3-year, $300,000 award will give Rochester the resources necessary to support further development of as many as 30 projects per year. Funds may be used
Dr. Goldman’s human glial mouse model has been written up in New Scientist. The idea is not to mimic fiction, but to advance our understanding of human brain diseases by studying them in whole mouse brains rather than in dishes. The altered mice still have
Four prominent Rochester researchers shared the state of their research and their experiences discovering and developing useful drugs. Mark Noble, Ph.D., (Biomedical Genetics), Paul Dunman, Ph.D. (Microbiology & Immunology), Harold Smith, Ph.D. (Biochemistry & Biophysics), and Richard Phipps, Ph.D. (Environmental Medicine) all spoke about some
High Tech Rochester’s Lennox Tech Enterprise Center, by virtue of its association with the University of Rochester, is a tax-free zone under the new START-UP NY economic development program. Taking advantage of HTR’s designation, PharmAdva LLC (www.pharmadva.com), a startup healthcare technology company with roots at
The University of Rochester has been identified by the journal Nature Biotechnology as one of the top 10 universities in the nation for the impact of its life sciences research. “This recognition reflects not only the University’s success in attracting federal research funding, but our ability to
They started with 6,932 applications from 96 countries and all 50 states. On 30 October 2014, the 11 finalists pitched their business plans to the judges. And the results are . . . Click here
PharmAdva LLC, a medical device manufacturer, has been approved to participate in the START-UP NY economic development program. The company will locate in High Tech Rochester’s (HTR) Lennox Tech Enterprise Center in Henrietta. Read More
By KERRY FELTNER Rochester Business Journal October 8, 2014 Adarza BioSystems Inc. has completed its final tranche of fundraising, reaching a total of $6.8 million. The funds will be used toward development of its immunoassay product and will accelerate development of even more sensitive tests for
Applications for HTR’s Pre-Seed Workshop (early this November) are being accepted through 24 October. Sign up here: http://htr.org/pre-seed-workshop-application. In addition to teams, the PSW is looking for Idea Champions. An Idea Champion is someone who works with a workshop team to explore opportunities in an
The fall 2014 round of the Technology Development Fund (TDF) has started. The TDF awards winning applications from faculty, staff, or students up to $100,000 to develop their technology to a commercial endpoint. A submitted invention disclosure to UR Ventures is required for an application.
As of Wednesday, 17 September 2014 UR Ventures has moved to a new location in the Saunders Research Building. We have kept our mailing address, all of our phone numbers, and e-mail addresses. The only difference is our physical location — SRB suite B360. The
Researchers at the University of Rochester Medical Center and University of Nebraska Medical Center have received a $3.4 million grant from the National Institutes of Health to study an experimental drug combination that appears to rid white blood cells of HIV and keep the infection
Rochester Business Journal 12 August 2014 The Entrepreneurs Network is soliciting applications for its 17th class, with sessions to begin next month. The class will meet monthly at High Tech Rochester Inc. in Henrietta and other venues in the Rochester area beginning Sept. 18 and